Skip to content

Effect of Etanercept medicine in low back pain associated with leg pain

Effect of Transforaminal Epidural Etanercept on Lumbar Radicular Pain: A Prospective Interventional Study - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/11/059887
Enrollment
30
Registered
2023-11-15
Start date
Unknown
Completion date
Unknown
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M995- Intervertebral disc stenosis of neural canal

Interventions

Intervention1: Transforaminal Epidural Injection: Dose: 5 mg of Etanercept Frequency: Once Route: Transforaminal Epidural Duration: 10 minutes Control Intervention1: Tumour necrosis Factor Alpha (TNF

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. History of segmental low back pain of lumbar origin with or without radiation to the unilateral lower limb below the knee of more than 3 months duration. 2. History of predominant leg pain over back pain. 3.Radicular pain not responding to oral medications and physiotherapy. 4. Pain involving up to two segmental levels in lumbar area. 5. Average pain score of =5 on an 11-point NRS. 6.Computed tomography/Magnetic resonance imaging evidence of nerve root pain

Exclusion criteria

Exclusion criteria: 1. Patient refusal to participate. 2. History of previous back surgery or steroid injections 3. Severe spinal stenosis. 4. Any condition known to be amenable to TNF-alpha inhibitors e.g Spondyloarthropathy and chron’s disease. 5. Systemic infections or Infection at the site of injection. 6. Contrast allergy Or local anaesthetic allergy

Design outcomes

Primary

MeasureTime frame
Decrease in Pain Score measured by NRSTimepoint: before procedure immediate post procedure 2week 1month 2months & 3months post procedure

Secondary

MeasureTime frame
Modified Oswestry Disability QuestionnaireTimepoint: before procedure After procedure 2 weeks 1 month 2 months & 3 months;TNF alphaTimepoint: before intervention & 2 week after intervention

Countries

India

Contacts

Public ContactSukhdeo Satyanarayan Gupta

All India Institute of Medical Science Rishikesh

ajitdr.ajit@gmail.com9910789377

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026